Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma.

@article{Kopp2012TumorSA,
  title={Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma.},
  author={Christine Kopp and Marilena Theodorou and Nektarios Poullos and Vesna Jacob and Sabrina T. Astner and Michael M Molls and A A Grosu},
  journal={International journal of radiation oncology, biology, physics},
  year={2012},
  volume={82 3},
  pages={1262-7}
}
PURPOSE To evaluate tumor control and side effects associated with fractionated stereotactic radiotherapy (FSRT) in the management of residual or recurrent nonfunctioning pituitary adenomas (NFPAs). METHODS AND MATERIALS We assessed exact tumor volume shrinkage in 16 patients with NFPA after FSRT. All patients had previously undergone surgery. Gross tumor volume (GTV) was outlined on contrast-enhanced magnetic resonance imaging (MRI) before and median 63 months (range, 28-100 months) after… CONTINUE READING